Institutions / CVI Holdings, LLC
CVI Holdings, LLC
CIK 1728194 · Institution · as of Jun 30, 2024
Portfolio value
$107.84M
Positions
143
As of
Jun 30, 2024
Portfolio trend
Portfolio value
$107.84M+1.5%Positions
143-8.9%Top holdings
Jun 30, 2024View all 143 →
| Company | Value | % of portfolio |
|---|---|---|
| Flutter Entertainment plcFLUT | $53.65M | 49.7% |
| Skye Bioscience, Inc.SKYE | $5.44M | 5.0% |
| Inmune Bio, Inc.INMB | $5.26M | 4.9% |
| Gp-Act III Acquisition Corp | $4.61M | 4.3% |
| Azz IncAZZ | $3.18M | 3.0% |
| Flag Ship Acquisition CorpFSHP | $3.14M | 2.9% |
| IB Acquisition Corp.IBAC | $2.49M | 2.3% |
| Haymaker Acquisition Corp. 4HYAC | $2.36M | 2.2% |
| AGRICULTURE and NATURAL SOLUTIANSC | $2.07M | 1.9% |
| Iron Horse Acquisitions Corp.IROH | $1.93M | 1.8% |
| Bayview Acquisition CorpBAYA | $1.47M | 1.4% |
| Trailblazer Merger Corp ITBMC | $1.40M | 1.3% |
| Nyxoah SA | $1.29M | 1.2% |
| Goldenstone Acquisition Ltd.GDST | $1.23M | 1.1% |
| CARGO Therapeutics, Inc.CRGX | $1.15M | 1.1% |
| Nabors Energy Transition Corp. IINETB | $1.15M | 1.1% |
| Bukit Jalil Global Acquisition 1 Ltd.BUJA | $1.08M | 1.0% |
| DT Cloud Acquisition Corp.DYCQ | $1.04M | 1.0% |
| Keen Vision Acquisition CorporationKVAC | $1.03M | 1.0% |
| Lionheart Holdings | $1.00M | 0.9% |
| Melar Acquisition Corp. I | $1.00M | 0.9% |
| Oak Woods Acquisition CorpOAKU | $974.7K | 0.9% |
| Regulus Therapeutics Inc.RGLS | $715.8K | 0.7% |
| Consonance-HFW Acquisition Corp.SRZN | $710.7K | 0.7% |
| Tmt Acquisition Corp | $692.4K | 0.6% |
Activity
Jun 30, 2024View full history →
InsidersInstitutions
This fund's quarter-over-quarter position changes — what it's buying and selling.| Date | Action | Company | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|
| Q1 2024 as of | New Other (per filing) | Flutter Entertainment plc common | $58.10M | +294K | 294,180 53.87% of portfolio | high |
| Q1 2021 as of | Exit Other (per filing) | 049284201 | $-50.64M | -4.8M -100.00% | 0 | high |
| Q4 2022 as of | New Other (per filing) | IBRX ImmunityBio, Inc. common | $38.58M | +7.6M | 7,609,166 35.77% of portfolio | medium |
| Q1 2023 as of | Exit Other (per filing) | IBRX |